Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-27 @ 9:28 PM
Study NCT ID:
NCT00960895
Status:
COMPLETED
Last Update Posted:
2011-10-27
First Post:
2009-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pulmonary Hypertension in Lymphangioleiomyomatosis
Sponsor:
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Organization:
Study Overview
Official Title:
Observational Study of Patients With Lymphangioleiomyomatosis and Pulmonary Hypertension
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LAM-PH
Brief Summary:
This is a descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension.
Detailed Description:
Descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension This will include modality of diagnosis of lLymphangioleiomyomatosis, results of right-sided heart catheterization, and pulmonary function tests
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: